Evidence map›Paper›PMID 35407522›Full record

ArticleJournal of clinical medicine2022

Differentiating Malignant from Benign Pigmented or Non-Pigmented Skin Tumours-A Pilot Study on 3D Hyperspectral Imaging of Complex Skin Surfaces and Convolutional Neural Networks.

Vivian Lindholm, Anna-Maria Raita-Hakola, Leevi Annala, Mari Salmivuori, Leila Jeskanen, Heikki Saari, Sari Koskenmies, Sari Pitkänen, Ilkka Pölönen, Kirsi Isoherranen and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Vivian LindholmDepartment of Dermatology and Allergology, University of Helsinki and Helsinki University Hospital, 00290 Helsinki, Finland.ORCID 0000-0003-2707-0861
Anna-Maria Raita-HakolaFaculty of Information Technology, University of Jyväskylä, 40100 Jyväskylä, Finland.ORCID 0000-0002-5984-609X
Leevi AnnalaFaculty of Information Technology, University of Jyväskylä, 40100 Jyväskylä, Finland.ORCID 0000-0002-8297-8859
Mari SalmivuoriDepartment of Dermatology and Allergology, University of Helsinki and Helsinki University Hospital, 00290 Helsinki, Finland.
Leila JeskanenDepartment of Dermatology and Allergology, University of Helsinki and Helsinki University Hospital, 00290 Helsinki, Finland.
Heikki SaariVTT Technical Research Centre of Finland, 02150 Espoo, Finland.
Sari KoskenmiesDepartment of Dermatology and Allergology, University of Helsinki and Helsinki University Hospital, 00290 Helsinki, Finland.
Sari PitkänenDepartment of Dermatology and Allergology, University of Helsinki and Helsinki University Hospital, 00290 Helsinki, Finland.
Ilkka PölönenFaculty of Information Technology, University of Jyväskylä, 40100 Jyväskylä, Finland.ORCID 0000-0002-5129-7364
Kirsi IsoherranenDepartment of Dermatology and Allergology, University of Helsinki and Helsinki University Hospital, 00290 Helsinki, Finland.
Annamari RankiDepartment of Dermatology and Allergology, University of Helsinki and Helsinki University Hospital, 00290 Helsinki, Finland.
University of Helsinki · FIUniversity of Jyväskylä · FIVTT Technical Research Centre of Finland · FI

Funding

Academy of Finland 314519
6 · The paper itself

Abstract

Several optical imaging techniques have been developed to ease the burden of skin cancer disease on our health care system. Hyperspectral images can be used to identify biological tissues by their diffuse reflected spectra. In this second part of a three-phase pilot study, we used a novel hand-held SICSURFIS Spectral Imager with an adaptable field of view and target-wise selectable wavelength channels to provide detailed spectral and spatial data for lesions on complex surfaces. The hyperspectral images (33 wavelengths, 477-891 nm) provided photometric data through individually controlled illumination modules, enabling convolutional networks to utilise spectral, spatial, and skin-surface models for the analyses. In total, 42 lesions were studied: 7 melanomas, 13 pigmented and 7 intradermal nevi, 10 basal cell carcinomas, and 5 squamous cell carcinomas. All lesions were excised for histological analyses. A pixel-wise analysis provided map-like images and classified pigmented lesions with a sensitivity of 87% and a specificity of 93%, and 79% and 91%, respectively, for non-pigmented lesions. A majority voting analysis, which provided the most probable lesion diagnosis, diagnosed 41 of 42 lesions correctly. This pilot study indicates that our non-invasive hyperspectral imaging system, which involves shape and depth data analysed by convolutional neural networks, is feasible for differentiating between malignant and benign pigmented and non-pigmented skin tumours, even on complex skin surfaces.

Indexed as

biomedical optical imagingconvolutional neural networkshyperspectral imagingnon-invasive imagingoptical modellingphotometric stereoskin cancerskin imaging

Identifiers

PMID35407522
PMCPMC8999463
OpenAlexW4220663311

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.